Church & Dwight Co., Inc. · NYSE (us_market)
Consumer Defensive · Household & Personal Products · United States
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2022-07-28$96.21 RISE2022-10-07$70.72 PEAK2022-12-02$83.07 127d | -26.5% 71d | Missed | Missed | — | — | +17.5% 56d | Missed |
DROP2022-04-27$104.16 RISE2022-06-15$81.50 PEAK2022-07-28$96.21 92d | -21.8% 49d | Missed | Missed | — | — | +18.0% 43d | Missed |
DROP2020-10-27$92.23 RISE2021-03-04$77.92 PEAK2021-04-21$89.89 176d | -15.5% 128d | Missed | Missed | — | — | +15.4% 48d | Missed |
DROP2020-02-21$76.61 RISE2020-03-25$60.30 PEAK2020-06-18$77.82 118d | -21.3% 33d | Missed | Missed | — | — | +29.1% 85d | Missed |
PG pairs broad category reach with innovation-led execution, while CHD is leaning on focused, value-driven brands and distribution expansion.
Here's why Wall Street is overlooking one of the most compelling consumer goods stocks in the pet and garden industry.
Here's why Wall Street is overlooking one of the most compelling consumer goods stocks in the pet and garden industry.
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Get this weekly dividend update on Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend dates and pay dates.
Investors need to pay close attention to CHD stock based on the movements in the options market lately.
Investors need to pay close attention to CHD stock based on the movements in the options market lately.
If you are wondering whether Church & Dwight at around US$95.75 is offering fair value or not, a good starting point is to compare the recent share performance with what current valuation metrics are indicating. The stock has returned 2.4% over the past week, is down 1.2% over the past month, and sits at a 15.9% gain year to date, with a 0.2% return over the last year. Taken together, this gives a mixed picture of momentum and sentiment. Recent coverage has focused on Church & Dwight as a...
If you are wondering whether Church & Dwight at around US$95.75 is offering fair value or not, a good starting point is to compare the recent share performance with what current valuation metrics are indicating. The stock has returned 2.4% over the past week, is down 1.2% over the past month, and sits at a 15.9% gain year to date, with a 0.2% return over the last year. Taken together, this gives a mixed picture of momentum and sentiment. Recent coverage has focused on Church & Dwight as a...
Church & Dwight has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Church & Dwight has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Church & Dwight (NYSE:CHD) and the best and worst performers in the household products industry.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Church & Dwight (NYSE:CHD) and the best and worst performers in the household products industry.
PG's U.S. Baby Care slump remains a weak spot, but strong global growth and targeted investments suggest it is a fixable issue, not a long-term drag.
PG's U.S. Baby Care slump remains a weak spot, but strong global growth and targeted investments suggest it is a fixable issue, not a long-term drag.
Church & Dwight’s first quarter results saw sales remain flat year over year, but organic revenue growth outpaced category averages, driven by volume rather than price. Management credited strong performance in core brands like ARM & HAMMER, TheraBreath, and Hero, as well as continued execution in both e-commerce and traditional retail. CEO Richard Dierker noted, “Our portfolio, with its balance of value and premium offerings, continues to perform well in this type of environment, supported by s
Church & Dwight’s first quarter results saw sales remain flat year over year, but organic revenue growth outpaced category averages, driven by volume rather than price. Management credited strong performance in core brands like ARM & HAMMER, TheraBreath, and Hero, as well as continued execution in both e-commerce and traditional retail. CEO Richard Dierker noted, “Our portfolio, with its balance of value and premium offerings, continues to perform well in this type of environment, supported by s
PG slides 9% in three months as inflation, margin pressure and weak guidance weigh on sentiment despite broad-based sales growth.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| CHD | -0.41% | -8.00% | +14.05% | -2.73% |
| XLP | -1.50% | -6.54% | +6.73% | +0.10% |
| Alpha (stock − sector) | +1.09% | -1.47% | +7.32% | -2.82% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 14.00M | $1.31B | 0.05% | Added+0.9% | 2026-03-31 |
| FidelityFMR | fundamental | 1.63M | $152.11M | 0.01% | Added+42.2% | 2026-03-31 |
| DEShaw | quant | 760.7K | $70.99M | 0.04% | Added+29.7% | 2026-03-31 |
| TwoSigma | quant | 585.6K | $54.65M | 0.04% | Trimmed-43.9% | 2026-03-31 |
| RenTech | quant | 190.7K | $17.80M | 0.03% | Added+41.7% | 2026-03-31 |
| CapResearch | fundamental | 105.9K | $9.93M | 0.00% | New | 2026-03-31 |
| Wellington | fundamental | 71.4K | $6.67M | 0.00% | Trimmed-24.3% | 2026-03-31 |
| Bridgewater | macro | 18.5K | $1.72M | 0.01% | Trimmed-34.9% | 2026-03-31 |
| TRowePrice | fundamental | 336.3K | $31.39K | 0.00% | Trimmed-4.9% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | Buchert Brian D | EVP of Strategy, M&A, and BP | A Grant / award(deriv) | 6 | $94.05 | +$547 |
| 2026-05-18 | Dierker Richard A | President and CEO | A Grant / award(deriv) | 46 | $94.05 | +$4.3K |
| 2026-05-14 | Price Penry W | Director | M Option exercise(deriv) | 5,960 | — | +$0 |
| 2026-05-14 | Price Penry W | Director | S Open-market sale | 5,960 | $94.86 | −$565.3K |
| 2026-05-14 | Price Penry W | Director | M Option exercise | 5,960 | $49.62 | +$295.7K |
| 2026-05-06 | CASHAW BRAD | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | CASHAW BRAD | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | Yoler Laurie | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | Yoler Laurie | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | WINKLEBLACK ARTHUR B | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | WINKLEBLACK ARTHUR B | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | Vergis Janet S. | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | Vergis Janet S. | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | SHEARER ROBERT K | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | SHEARER ROBERT K | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | Price Penry W | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | Price Penry W | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | Smith Michael R | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | Smith Michael R | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | Saligram Ravichandra Krishnamurty | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | Saligram Ravichandra Krishnamurty | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | IRWIN BRADLEY C | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | IRWIN BRADLEY C | Director | A Grant / award | 920 | — | +$0 |
| 2026-05-06 | Saideman Susan G | Director | A Grant / award(deriv) | 3,060 | — | +$0 |
| 2026-05-06 | Saideman Susan G | Director | A Grant / award | 920 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-31upcoming | 0.89 | — | — |
| 2026-05-01 | 0.93 | 0.95 | +2.23% |
| 2026-01-30 | 0.83 | 0.86 | +3.02% |
| 2025-10-31 | 0.74 | 0.81 | +9.93% |
| 2025-08-01 | 0.86 | 0.94 | +9.51% |
| 2025-05-01 | 0.90 | 0.91 | +1.42% |
| 2025-01-31 | 0.77 | 0.77 | +0.42% |
| 2024-11-01 | 0.68 | -0.31 | -145.89% |
| 2024-08-02 | 0.84 | 0.93 | +10.09% |
| 2024-05-02 | 0.87 | 0.96 | +10.07% |
| 2024-02-02 | 0.65 | 0.65 | +0.63% |
| 2023-11-03 | 0.69 | 0.74 | +7.55% |
| 2023-07-28 | 0.80 | 0.92 | +15.41% |
| 2023-04-27 | 0.77 | 0.85 | +11.08% |
| 2023-02-03 | 0.60 | 0.62 | +3.15% |
| 2022-10-28 | 0.65 | 0.76 | +16.33% |